Orla Hardiman

Active 1986–2026

244
Papers
37,610
Citations
101
h-index
227
i10-index

Citations

Citations per year for Orla Hardiman1951: 11 citations1977: 2 citations1986: 5 citations1987: 1 citations1990: 2 citations1991: 1 citations1992: 3 citations1993: 5 citations1994: 2 citations1995: 4 citations1996: 3 citations1997: 3 citations1998: 5 citations1999: 7 citations2000: 9 citations2001: 16 citations2002: 21 citations2003: 35 citations2004: 28 citations2005: 31 citations2006: 46 citations2007: 103 citations2008: 93 citations2009: 138 citations2010: 159 citations2011: 245 citations2012: 287 citations2013: 322 citations2014: 326 citations2015: 345 citations2016: 407 citations2017: 461 citations2018: 339 citations2019: 1,490 citations2020: 1,957 citations2021: 1,934 citations2022: 1,503 citations2023: 1,204 citations2024: 1,797 citations2025: 834 citations2026: 38 citations1952–1976: no citations, so these years are not shown1978–1985: no citations, so these years are not shown1988–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,469 citing papers, 19.2% of this breakdownUnited Kingdom: 1,333 citing papers, 10.4% of this breakdownItaly: 1,063 citing papers, 8.3% of this breakdownGermany: 778 citing papers, 6% of this breakdownChina: 702 citing papers, 5.5% of this breakdownAustralia: 626 citing papers, 4.9% of this breakdownCanada: 560 citing papers, 4.3% of this breakdownNetherlands: 552 citing papers, 4.3% of this breakdownFrance: 509 citing papers, 4% of this breakdownSpain: 367 citing papers, 2.8% of this breakdownIreland: 336 citing papers, 2.6% of this breakdownSweden: 308 citing papers, 2.4% of this breakdown
0%19.2%Other 25.3%

Fields

  • Medicine70.5%
  • Biochemistry, Genetics and Molecular Biology15.2%
  • Neuroscience8.4%
  • Health Professions1.1%
  • Computer Science1%
  • Engineering0.8%
  • Other3%

Topics

  • Amyotrophic Lateral Sclerosis Research19.9%
  • Neurogenetic and Muscular Disorders Research9.3%
  • Parkinson's Disease Mechanisms and Treatments4.5%
  • Genetic Neurodegenerative Diseases4.1%
  • Alzheimer's disease research and treatments3.3%
  • Neurological diseases and metabolism2.2%
  • Other56.7%

Coauthors

All papers

Open in search
  1. Amyotrophic lateral sclerosis

    Authors: , , , , , , , , - Nature Reviews Disease Primers 2017 cited by 1,382

  2. Amyotrophic lateral sclerosis

    Authors: , , , , , , , - The Lancet 2011 cited by 2,469

  3. Amyotrophic lateral sclerosis

    Authors: , , , , , , - The Lancet 2017 cited by 1,264

  4. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis

    Authors: , , , , , , - The Lancet Neurology 2022 cited by 440

  5. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis

    Authors: , , , , , , - The Lancet Neurology 2022 cited by 385

  6. A proposal for new diagnostic criteria for ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical Neurophysiology 2020 cited by 574

  7. Prognostic factors in ALS: A critical review

    Authors: , , , , , , , - Amyotrophic Lateral Sclerosis 2009 cited by 1,149

  8. The epidemiology of ALS: a conspiracy of genes, environment and time

    Authors: , - Nature Reviews Neurology 2013 cited by 883

  9. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Corcia, Philippe Couratier, Markus Weber, Julian Großkreutz, Albert C. Ludolph, Susanne Petri, Mamede de Carvalho, Philip Van Damme, Kevin Talbot, Martin R. Turner, Pamela J. Shaw, Ammar Al‐Chalabi, Adriano Chiò, Orla Hardiman, Karel G.M. Moons, Jan H. Veldink, Leonard H. van den Berg - The Lancet Neurology 2018 cited by 517

  10. Improving clinical trial outcomes in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , - Nature Reviews Neurology 2020 cited by 291

  11. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force

    Authors: , , , , , , , , , , , , , , , - European Journal of Neurology 2011 cited by 1,104

  12. Detection of long repeat expansions from PCR-free whole-genome sequence data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Edmund Jin Rui Neo, Karen Morrison, Pamela J. Shaw, Catherine Reeves, Lara Winterkorn, Nancy S. Wexler, David E. Housman, Christopher Ng, Alina Li, Ryan J. Taft, Leonard H. van den Berg, David Bentley, Jan H. Veldink, Michael A. Eberle - Genome Research 2017 cited by 437

  13. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , François Jacques, Yves Lapierre, Liesly Lee, Sarah A. Morrow, Michael Yeung, Michal Dufek, Eva Havrdová, Petr Kaňovský, Ivana Štětkářová, Marika Talábová, Jette Lautrup Frederiksen, Matthias Kant, Thor Petersen, Mads Ravnborg, Finn Sellebjerg, Laura Airas, Irina Elovaara, Juha-Pekka Erälinna, Taneli Sarasoja, Abdullatif Al Khedr, David Brassat, Bruno Brochet, William Camu, Marc Debouverie, David Laplaud, Christine Lebrun‐Frénay, Jean Pelletier, Patrick Vermersch, Sandra Vukusi, Karl Baum, Achim Berthele, Juergen Faiss, Peter Flachenecker, Reinhard Hohlfeld, Markus Krumbholz, Christoph Lassek, Mathias Maeurer, Sven G. Meuth, Tjalf Ziemssen, Orla Hardiman, Christopher McGuigan, Anat Achiron, Dimitrios Karussis, Roberto Bergamaschi, Vincenzo Brescia Morra, Giancarlo Comi, Salvatore Cottone, Luigi M.E. Grimaldi, Giovanni Luigi Mancardi, Luca Massacesi, Ugo Nocentini, Marco Salvetti, Elio Scarpini, Patrizia Sola, Gioacchino Tedeschi, María Trojano, Mauro Zaffaroni, Stephan Frequin, Raymond Hupperts, Joep Killestein, Hans M. Schrijver, Ronald Van Dijl, Erik van Munster, Maciej Czarnecki, Wiesław Drozdowski, Waldemar Fryze, Hanka Hertmanowska, Jan Ilkowski, Anna Kamińska, Gabriela Kłodowska-Duda and 90 more - The Lancet Neurology 2018 cited by 337

  14. Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis

    Authors: , , , - JAMA Neurology 2019 cited by 234

  15. Clinical diagnosis and management of amyotrophic lateral sclerosis

    Authors: , , - Nature Reviews Neurology 2011 cited by 614

  16. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2014 cited by 425

  17. Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michal Zabari, Patrick Vourc’h, Philippe Corcia, P. Couratier, Jesús S. Mora Pardina, Teresa Salas, Patrick A. Dion, Jay P. Ross, Robert D. Henderson, Susan Mathers, Pamela A. McCombe, Merrilee Needham, Garth Nicholson, Dominic B. Rowe, Roger Pamphlett, Karen A. Mather, Perminder S. Sachdev, Sarah Furlong, Fleur C. Garton, Anjali K. Henders, Tian Lin, Shyuan T. Ngo, Frederik J. Steyn, Leanne Wallace, Kelly L. Williams, Miguel Mitne Neto, Ruben J. Cauchi, Ian P. Blair, Matthew C. Kiernan, Vivian Drory, Mónica Povedano, Mamede de Carvalho, Susana Pinto, Markus Weber, Guy A. Rouleau, Vincenzo Silani, John E. Landers, Christopher E. Shaw, Peter M. Andersen, Allan F. McRae, Michael A. van Es, R. Jeroen Pasterkamp, Naomi R. Wray, Russell L. McLaughlin, Orla Hardiman, Kevin P. Kenna, Ellen Tsai, Heiko Runz, Ammar Al‐Chalabi, Leonard H. van den Berg, Philip Van Damme, Jonathan Mill, Jan H. Veldink, Bastiaan T. Heijmans, Peter A.C. t Hoen, Joyce van Meurs, Rick Jansen, Lude Franke, Dorret I. Boomsma, René Pool, Jenny van Dongen, Joukje J. Hottenga, Marleen M. J. van Greevenbroek, Coen D.A. Stehouwer, Carla Kallen, Casper G. Schalkwijk, Cisca Wijmenga, Lude Franke, Sasha Zhernakova, Ettje F. Tigchelaar and 54 more - Science Translational Medicine 2022 cited by 93

  18. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Couratier, Orla Hardiman, Russell McLaughin, Marc Gotkine, Vivian E. Drory, Nicola Ticozzi, Vincenzo Silani, Jan H. Veldink, Leonard H. van den Berg, Mamede de Carvalho, Jesús S. Mora Pardina, Mónica Povedano, Peter M. Andersen, Markus Weber, Nazlı Başak, Ammar Al‐Chalabi, Christopher E. Shaw, Pamela J. Shaw, Karen Morrison, John E. Landers, Jonathan D. Glass, Jan H. Veldink, Laura Ferraiuolo, Pamela J. Shaw, M Snyder - Neuron 2022 cited by 122

  19. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank Baas, Anneke J. van der Kooi, Marianne de Visser, Anneloor L.M.A. ten Asbroek, Peter C. Sapp, Diane McKenna‐Yasek, Meraida Polak, Seneshaw Asress, José Luís Muñoz-Blanco, Tim M. Strom, Thomas Meitinger, Karen Morrison, Giuseppe Lauria, Kelly L. Williams, P. Nigel Leigh, Garth A. Nicholson, Ian P. Blair, Claire S. Leblond, Patrick A. Dion, Guy A. Rouleau, Hardev Pall, Pamela J. Shaw, Martin R. Turner, Kevin Talbot, Franco Taroni, Khrista Boylan, Marka van Blitterswijk, Rosa Rademakers, Jesús Esteban‐Pérez, Alberto García‐Redondo, Phillip Van Damme, Wim Robberecht, Adriano Chiò, Cinzia Gellera, Carsten Drepper, Michael Sendtner, Antonia Ratti, Jonathan D. Glass, Jesús S. Mora, Nazlı Başak, Orla Hardiman, Albert C. Ludolph, Peter M. Andersen, Jochen H. Weishaupt, Robert H. Brown, Ammar Al‐Chalabi, Vincenzo Silani, Christopher E. Shaw, Leonard H. van den Berg, Jan H. Veldink, John E. Landers - Nature Genetics 2016 cited by 294

  20. Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2024 cited by 70

  21. A revision of the El Escorial criteria - 2015

    Authors: , , , , , , , - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2015 cited by 478

  22. Correction: Amyotrophic lateral sclerosis

    Authors: , , , , , , , , - Nature Reviews Disease Primers 2017 cited by 359

  23. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alberto García‐Redondo, Jesús Esteban‐Pérez, Cinzia Tiloca, Federico Verde, Stefano Duga, Nigel Leigh, Hardev Pall, Karen Morrison, Ammar Al‐Chalabi, Pamela J. Shaw, Janine Kirby, Martin R. Turner, Kevin Talbot, Orla Hardiman, Jonathan D. Glass, Jacqueline de Belleroche, Masatoshi Maki, Stephen E. Moss, Christopher C.J. Miller, Cinzia Gellera, Antonia Ratti, Safa Al‐Sarraj, Robert H. Brown, Vincenzo Silani, John E. Landers, Christopher E. Shaw - Science Translational Medicine 2017 cited by 247

  24. The multistep hypothesis of ALS revisited

    Authors: , , , , , , , , , , , , , , , , , , , , - Neurology 2018 cited by 216